about
The effect of surface nanometre-scale morphology on protein adsorptionKilling cancer cells by targeted drug-carrying phage nanomedicinesNanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug deliveryAn orally delivered small-molecule formulation with antiangiogenic and anticancer activityTargeted drug-carrying bacteriophages as antibacterial nanomedicinesVersatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined RoutingDevelopment of polymeric micelles for targeting intractable cancersBreast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesTweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingNanoparticle-mediated drug delivery for treating melanomaTargeting the Eph System with Peptides and Peptide ConjugatesNoninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyRecent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketPolymeric micelles for multi-drug delivery in cancerAdvances in the use of nanocarriers for cancer diagnosis and treatmentEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive systemRecent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic AgentsDrug Carriers: Not an Innocent Delivery ManPolymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug deliveryPolymeric nanoparticles for targeted treatment in oncology: current insightsBio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar ratsInteractions of nanomaterials and biological systems: Implications to personalized nanomedicineA novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancerConstruction and application of elastin like polypeptide containing IL-4 receptor targeting peptideA polymer-based magnetic resonance tracer for visualization of solid tumors by 13C spectroscopic imagingCurcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cellsPET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing MiceIn Vivo Targeting of Metabolically Labeled Cancers with Ultra-Small Silica NanoconjugatesEvaluating Adverse Effects of Inhaled Nanoparticles by Realistic In Vitro TechnologyClinical Translation of Nanomedicine.Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.Biodegradable polymeric nanoparticles containing gold nanoparticles and Paclitaxel for cancer imaging and drug delivery using photoacoustic methods.Neural Cell Chip Based Electrochemical Detection of NanotoxicityChemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionStimuli-Responsive Materials for Controlled Release of Theranostic Agents.
P2860
Q21136246-21B730A8-9ABD-4060-84A6-EC71797B8075Q21256651-5F8FB937-86D8-4885-B90A-2779FD511B75Q24599399-FDFB0647-33D4-473B-961B-538D056C3B3BQ24616011-24F1767E-F570-4DE6-A6B4-B25B4DAA6210Q24649290-0CEFCDA7-3BFA-4B3F-893F-EC88D8173372Q24673452-0B76E72E-A3DF-41AC-9E5D-90750A7DF297Q26746171-2B5157DB-FBA4-4400-9906-5A7E6B061F5AQ26749611-AF615430-E313-436B-9A14-173D947DA947Q26783705-DA53FCD9-F9E5-48C9-9EBA-AA2E8DDD754AQ26785347-14CFEE3E-1054-4547-BF58-5F6E3F2439D7Q26798379-65E84C0B-38C5-4D7E-B3B9-BE9A3A785E10Q26799461-6F202964-F862-4B7B-83B6-9321325985EDQ26822871-47EA0A30-1A9F-4A4C-88A7-ABD2B2D6A5E9Q26827999-490AB719-4EFF-4276-A8D7-054E565191DBQ27010654-E01A7C72-E506-4A83-A0D5-D6C25DAF35C7Q27015050-A12F82E2-33A1-4824-955E-415877D6324EQ27025861-EEAA1F00-8BD2-4605-B87B-CB332BF55B65Q28070065-5F0ED013-B9A8-4B99-841B-3D50B1FC7FD0Q28073956-6F4E321A-D873-47BC-9843-7F4641F404D6Q28078448-C49DD101-556D-4AD1-844B-0CD199A5AF1DQ28079367-BD0343B0-D47B-4539-923A-D7CD67896225Q28079607-3F255EEE-D125-4566-B5D0-84773665579CQ28082414-E370129D-6061-49C8-999A-BE13BA7FC364Q28085664-47219E21-1B3D-4680-B71A-FBCE7CFCEA9CQ28087243-7FB1F7B5-599B-4861-911B-C439FEF1268EQ28387832-3E9038E4-45CB-43A5-A80B-0F0D85709860Q28391849-AB845C04-CA93-4CCF-B54C-9A49783F7E27Q28474508-2CBD353F-AD39-4878-B67E-6C9E3A178C4AQ28536690-8DC0D0FE-CF3B-41FF-9BBE-F24D925457C1Q28540556-3C75210D-B439-431D-B057-E6D5AABFC430Q28543521-624DC6E5-5845-477C-BE83-EBC0D1ED55B4Q28546012-54C3FDEC-F277-44B5-AEA9-98B188557F3BQ28828629-188D965A-6914-4FCF-9F26-7499220E472FQ29248736-137F9EC4-F0AF-4977-80E6-056856040EA1Q30355939-D53CA75D-BE7C-4E7A-8B16-519AFAEB11D1Q30361067-EA55DA4A-18C8-4AB3-8AA2-7569329FE1E5Q30369570-48C5D5D8-4981-4D34-ACC4-5B49AAB447A4Q30378116-29586796-E7D3-4C01-9CC7-9C6A53C14230Q30399577-A8B29716-981F-4DAE-8328-B2CB0A9B08DEQ30406730-33E615B7-39DD-4473-BDFA-21E1E997E26D
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Polymer conjugates as anticancer nanomedicines.
@ast
Polymer conjugates as anticancer nanomedicines.
@en
type
label
Polymer conjugates as anticancer nanomedicines.
@ast
Polymer conjugates as anticancer nanomedicines.
@en
prefLabel
Polymer conjugates as anticancer nanomedicines.
@ast
Polymer conjugates as anticancer nanomedicines.
@en
P2860
P356
P1476
Polymer conjugates as anticancer nanomedicines.
@en
P2093
Ruth Duncan
P2860
P2888
P304
P356
10.1038/NRC1958
P407
P577
2006-08-10T00:00:00Z